{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By ROBERT CYRAN", "person": [{"firstname": "Robert", "rank": 1, "lastname": "CYRAN", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "385", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Health Insurance and Managed Care", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Presidential Election of 2016", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}], "lead_paragraph": "A public rebuke about drug prices by the president-elect makes what many dismissed as campaign rhetoric all too real.", "pub_date": "2017-01-12T20:48:43+0000", "document_type": "article", "source": "The New York Times", "snippet": "A public rebuke about drug prices by the president-elect makes what many dismissed as campaign rhetoric all too real....", "multimedia": [], "web_url": "http://www.nytimes.com/2017/01/12/business/dealbook/big-pharma-on-the-hot-seat.html", "slideshow_credits": null, "blog": [], "_id": "5877ebb195d0e0392607a67d", "headline": {"main": "Big Pharma on the Hot Seat", "content_kicker": "Breakingviews"}}